Literature DB >> 18041381

Somatotype in elderly type 2 diabetes patients.

Roberto Buffa1, Giovanni Floris, Paolo F Putzu, Luciano Carboni, Elisabetta Marini.   

Abstract

Somatotyping is a practical technique for the description of physique. Individuals with Type 2 diabetes are characterized by physical peculiarities, such as overweight, obesity and a central pattern of body fat distribution. Somatotype applications to diabetes are limited. The objective of this study is to describe the somatotype of elderly type 2 diabetes patients. The sample consisted of 110 patients with type 2 diabetes (45 men, mean age 69.4 +/- 7.0 years; 65 women, mean age 72.9 +/- 7.1 years). The pathological subjects were compared with a control group consisting of 280 healthy individuals (134 men, mean age 74.2 +/- 7.3 years; 146 women, mean age 74.9 +/- 7.4 years). The Heath-Carter somatotype was applied. Diabetic men and women (mean somatotype, respectively: 6.8-5.6-0.6 and 8.6-6.4-0.2) presented significantly higher values of endomorphy than the controls (p = 0.043 in men, p = 0.003 in women); men also had a lower mesomorphic component (p = 0.000). The somatotype method revealed physical peculiarities in type 2 diabetes patients. The marked endomorphy in the pathological individuals can be related to general fatness, which is a well known disease risk factor. The somatotype appears to be a suitable technique for the assessment of physique in type 2 diabetes patients.

Entities:  

Mesh:

Year:  2007        PMID: 18041381

Source DB:  PubMed          Journal:  Coll Antropol        ISSN: 0350-6134


  2 in total

1.  The relation of somatotypes and stress response to central serous chorioretinopathy.

Authors:  Roy Schwartz; Assaf Rozenberg; Anat Loewenstein; Michaella Goldstein
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-09-05       Impact factor: 3.117

2.  Body composition and personality traits in so-Yang type males.

Authors:  Jiwon Yoon; Jiho Nam; Chae Hun Leem; Jong Yeol Kim
Journal:  BMC Complement Altern Med       Date:  2017-08-22       Impact factor: 3.659

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.